Outcomes of multiple myeloma (MM) patients with del 17p as a sole high risk cytogenetic abnormality who underwent either single or tandem upfront autologous stem cell transplant approaches in EBMT centres between 2016 and 2022
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Conal Houstoun, Patrick Hayden, Dirk-Jan Eikema, Linda Koster, Sandra Sauer, Annoek Broers, Neil Rabin, Tobias Gedde-Dahl, Britta Besemer, Matthew Collin, Luisa Giaccone, Kristina Carlson, Thomas Pabst, Deborah Richardson, Jean Marc Schiano De Colella, Bertrand Arnulf, Mathias Hänel, Christine Schuermans, Francesco Zaja, Kavita Raj, Joanna Drozd-Sokolowska, Laurent Garderet, Nico Gagelmann, Meral Beksac, Donal McLornan
Institutions: Trinity College Dublin, St. James's Hospital, European Society for Blood and Marrow Transplantation, Heidelberg University, Erasmus MC, Erasmus MC Cancer Institute, University College London, Oslo University Hospital, University of Tübingen, Royal Victoria Infirmary, Uppsala University Hospital, University Hospital of Bern, Southampton General Hospital, Institut Paoli-Calmettes, Hôpital Saint-Louis, Klinikum Chemnitz, Azienda sanitaria universitaria Giuliano Isontina, Medical University of Warsaw, Pitié-Salpêtrière Hospital, University Medical Center Hamburg-Eppendorf, Istinye University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417022456
Cites:
Cited by:
Related to: